According to Baudax Bio 's latest financial reports the company's current EPS (TTM) is -$107.73. In 2022 the company made an earnings per share (EPS) of -$279.95 an increase over its 2021 EPS that were of -$500.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$107.73 | -61.52% |
2022 | -$279.95 | -44.01% |
2021 | -$500.00 | -93.46% |
2020 | -$7,644 | 53.24% |
2019 | -$4,988 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -97.98% | ๐บ๐ธ USA |